Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

janssen_latest_logo_on_sign_closer

Janssen seals global inherited retinal disease partnership with gene therapy firm MeiraGTx

February 1, 2019 Medical Communications, Research and Development, Sales and Marketing Janssen, MeiraGTx, eye care, gene therapy, pharma

In a bid to boost its portfolio in the eye care space, Janssen has announced a global partnership with clinical-stage …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

February 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, England, NHS, Purdue, Vertex, insys, israel, oncology, pharma, top 10

Scandal dominated this week’s news after Sunrise Lee, a stripper turned Insys sales rep was alleged to have given a …
News
kymriah

Novartis’ CAR-T therapy Kymriah gets NICE green light in diffuse large B-cell lymphoma

February 1, 2019 Medical Communications, Sales and Marketing CAR-T, Cancer, Kymriah, NICE, Novartis, lymphoma, pharma

NICE has announced another momentous decision for lymphoma patients in England and Wales:, recommending Novartis’ chimeric antigen receptor T cell …
News
both_together

Repurposed drugs: The Supreme Court deals a blow to patentees

January 31, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Supreme Court, drug repurposing, feature, patents, pharma

Second medical use patents protect the discovery that an existing drug is effective to treat a new condition. But, following …
Feature
mylan_building

Mylan’s Wixela becomes first FDA-approved generic version of GSK’s Advair inhaler

January 31, 2019 Sales and Marketing Advair, COPD, FDA, Wixela, asthma, generic, pharma

Mylan’s Wixela has become the first generic version of GlaxoSmithKline’s Advair Diskus (fluticasone propionate and salmeterol inhalation powder) inhaler to …
News
richard_ridinger

Richard Ridinger resigns from CEO position at Lonza causing shares to plummet

January 30, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Lonza, Marc Funk, Richard Ridinger, Switzerland

Richard Ridinger, the CEO of Swiss biotechnology firm Lonza Group, will step down from his position in March of this …
Appointment
pharmafocus_janfeb_2019_cover

Read Pharmafocus January/February 2019 edition online now!

January 30, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, Counterfeit drugs, NHS, Pharmafocus, WHO, brexit, pharma, vaccines

We’re slowly edging towards warmer months, but the New Year brings more than just the promise of more amicable weather; …
News

Imbruvica combo scores expanded FDA approval in most common adult form of leukaemia

January 29, 2019 Manufacturing and Production, Sales and Marketing AbbVie, Cancer, Janssen, imbruvica, leukaemia, pharma

It’s big news for Janssen and AbbVie as it emerged that their jointly-developed Bruton’s tyrosine kinase (BTK) inhibitor Imbruvica (ibrutinib) …
News
alexander_hardy

Alexander Hardy returns to Genentech as new CEO

January 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Genentech, Roche, appointment, pharma

Genetech, the biotech subsidiary of Swiss firm Roche, has named its new CEO, revealing that Alexander Hardy will be returning …
News

Philip Hampton to step down from chairman role at GSK

January 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, UK, appointment, pharma

Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …
Appointment

Novartis warns of huge impact of no-deal Brexit

January 28, 2019 Sales and Marketing EU, Novartis, UK, brexit, no-deal, pharma

Swiss pharmaceutical company Novartis has called on the British government to ‘ensure continuity of supply’ in the case of a …
News
dw-anzcxqaqavhl

Head of opioid advisory panel criticises FDA for complacency in ongoing crisis

January 28, 2019 Medical Communications, Sales and Marketing Dsuvia, FDA, opioid crisis, opioids, pharma

The opioid crisis continues to be a top healthcare concern in the US, but the head of the FDA’s Anesthetic …
News

People in England will be able to pay the NHS to sequence their genetic data, if they share it with scientists

January 28, 2019 Sales and Marketing Alzheimer's, Cancer, England, NHS, genetic data, genomes, health

The NHS will provide paid-for health reports, informing patients as to the likelihood that they will develop diseases such as …
News
allergan

Allergan and St Regis Mohawk Tribe take patent ruling to Supreme Court

January 28, 2019 Sales and Marketing Allergan, Mohawk, Restasis, St Regis, eye drops, patents

Allergan and the St Regis Mohawk Tribe have asked the Supreme Court to defend a 2017 patent agreement which would …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

January 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Celgene, NHS, health, pharma, venlytxo

While American firm AbbVie gained approval for leukaemia drug Venlytxo, the NHS defeated the US multinational thus week in court, …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026